Avelios Medical is a German health technology company headquartered in Munich.^[3][5] Founded in 2020, it develops a modular hospital information system (HIS) designed to digitize hospital workflows, generate structured treatment data, and enable AI integration for improved patient care.^[1][5] The company's software platform focuses on treatment-oriented processes, modular microservices architecture, and data-driven applications, serving clients such as major German hospitals.^[6][7]

As of 2025, Avelios has raised over €37 million in funding and employs approximately 100 people, primarily software developers and medical professionals.^[8][9][1][4]

Avelios Medical was founded in 2020 in Munich by Christian Albrecht, a former McKinsey consultant; Dr. Sebastian Krammer, a physician; and Nicolas Jakob, a software engineer and deep learning expert.^[3][10][2] The company originated from a research project at Ludwig Maximilian University of Munich (LMU), where Dr. Krammer and Jakob explored artificial intelligence applications for diagnosing skin diseases.^[9][3] They identified limitations in existing hospital systems, particularly the lack of structured data, which hindered digitalization and AI usability.^[9][6] To address these issues, the founders decided to build a new hospital information system (HIS) from scratch rather than layering solutions onto legacy systems.^[10][3]

In 2021, the company raised an initial seed round, followed by a Series A in 2025.^[8][1][2]

In September 2025, Avelios announced a strategic partnership with SAP following SAP's decision to discontinue its healthcare administration and billing system, IS-H. The partnership aims to provide an integrated solution combining medical and business data, streamline end-to-end processes, enable AI applications in clinical and administrative workflows, and facilitate implementation through pre-designed integration scenarios.

Avelios develops a modular, cloud-ready hospital information system (HIS) that emphasizes treatment-oriented workflows, structured data capture, and AI integration. The platform uses a microservices architecture, allowing hospitals to implement modules incrementally for areas such as patient documentation, administration, billing, and patient portals.^[6][1]

Key features include:

• Structured, semantically annotated data with over 2,000 points per treatment based on SNOMED‑CT and ICD‑10, enabling AI applications, research, and workflow automation.^[4][11]
• Integration with standards like FHIR for interoperability with existing systems.^[12]
• AI-driven tools across clinical and administrative workflows such as voice-based documentation and decision support - powered by Explainable Machine Learning and Deep Learning models.^[1][2][13]
• A patient portal for digital admission, scheduling, and post-discharge management.^[1][2]

The system is designed to reduce administrative burdens, with studies cited by the company indicating doctors spend over three hours daily on such tasks.^[14] Data is stored in secure European data centers or on‑premises.^[1][2]

As of 2025, Avelios has won 14 customers representing more than 70 hospitals, including five university hospitals: LMU Munich, University Hospital Regensburg, Hannover Medical School (MHH), University Medical Center Mainz, and University Hospital Münster.

Avelios collaborates with established implementation partners including Adesso, Deloitte, and WMC Healthcare. The company reports having completed several major projects within comparatively short timeframes. At the University Hospital Regensburg, the company states it successfully implemented the system across nearly all departments within approximately one year.

Avelios has raised funding in multiple rounds to support team expansion and product development.

• In November 2021, the company secured €2 million in seed funding led by Revent, with participation from High-Tech Gründerfonds (HTGF) and business angels including founders of Amboss and Oviva.^[8]
• By 2021–2025, an additional €5 million was raised.^[9][15]
• In February 2025, Avelios closed a €30 million Series A round led by Sequoia Capital, with Revent and HTGF participating.^[1][2][3]

Avelios has received positive attention for its innovative approach amid Germany's hospital digitization challenges, particularly following SAP's market exit. Investors, including Sequoia partner Anas Biad, have praised the company's "depth and breadth" and its potential to deliver a "modern operating system" for healthcare.^[16][17]

Media outlets have highlighted its role in addressing inefficiencies, such as preventable medication errors (65,000 annual deaths in Germany) and administrative overload.^[14][2]

In 2024, Avelios was recognized among Munich’s leading startups on LinkedIn and was featured as WirtschaftsWoche’s “Startup of the Week.” The company was later included in the Sifted 100: DACH and CEE 2025 ranking (20th place), listed by VivaTech among Europe’s top seven healthcare startups, and featured in the Norrsken Impact/100 index.^[18][19][20]